Probable osteosarcoma risk after prolonged teriparatide treatment: comment on the article by Saag et al.
Tastekin
Nurettin
N
Zateri
Coskun
C
D050071:Bone Density Conservation Agents / Q000009:adverse effects; D001859:Bone Neoplasms / Q000139:chemically induced*; D004334:Drug Administration Schedule; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*; D012516:Osteosarcoma / Q000139:chemically induced*; D019379:Teriparatide / Q000009:adverse effects*
D050071:Bone Density Conservation Agents; D019379:Teriparatide